NCT04096586 Effects of Watermelon Consumption on Satiety and Digestive Health
| NCT ID | NCT04096586 |
| Status | Recruiting |
| Phase | — |
| Sponsor | San Diego State University |
| Condition | Satiety |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2019-08-01 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2019-08-01 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of the proposed research is to determine the effects of watermelon (fruit and rind blenderized) on satiety, metabolic markers, bowel habits, microbiome and weight management in children and adults
Eligibility Criteria
Inclusion Criteria: * Generally healthy subjects Exclusion Criteria: * Smoker * Pregnant woman * Required dietary supplement use * Required medication of metabolic disorders * Allergy to watermelon
Frequently Asked Questions
Who can join the NCT04096586 clinical trial?
This trial is open to participants of all sexes, aged 10 Years or older, up to 55 Years, studying Satiety. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04096586 currently recruiting?
Yes, NCT04096586 is actively recruiting participants. Visit ClinicalTrials.gov or contact San Diego State University to inquire about joining.
Where is the NCT04096586 trial being conducted?
This trial is being conducted at San Diego, United States.
Who is sponsoring the NCT04096586 clinical trial?
NCT04096586 is sponsored by San Diego State University. The trial plans to enroll 80 participants.